International Journal of Clinical Case Reports, 2025, Vol.15, No.5, 239-247 http://medscipublisher.com/index.php/ijmms 247 Tyagi A., and Pugazhenthi S., 2023, A promising strategy to treat neurodegenerative diseases by SIRT3 activation, International Journal of Molecular Sciences, 24(2): 1615. https://doi.org/10.3390/ijms24021615 Velpuri P., Patel P., Yazdani A., Abdi A., Rai V., and Agrawal D.K., 2024, Increased oxidative stress and decreased sirtuin-3 and FoxO3 expression following carotid artery intimal injury in hyperlipidemic Yucatan microswine, Cardiology and Cardiovascular Medicine, 8(1): 33. https://doi.org/10.26502/fccm.92920355 Wang T., Cao Y., Zheng Q., Tu J., Zhou W., He J., Zhong J., Chen Y., Wang J., Cai R., Zuo Y., Wei B., Fan Q.J., Yang J., Wu Y.C., Yi J., Li D.L., Liu M.Y., Wang C.G., Zhou A.W., Li Y., Wu X.F., Yang W., Chin Y.E., Chen G.Q., and Cheng J., 2019, SENP1-Sirt3 signaling controls mitochondrial protein acetylation and metabolism, Molecular Cell, 75(4): 823-834. https://doi.org/10.1016/j.molcel.2019.06.008 Wu Q.J., Zhang T.N., Chen H.H., Yu X.F., Lv J.L., Liu Y.Y., Liu Y.S., Zheng G., Zhao J.Q., Wei Y.F., Guo J.Y., Liu F.H., Chang Q., Zhang Y.X., Liu C.G., and Zhao Y.H., 2022, The sirtuin family in health and disease, Signal Transduction and Targeted Therapy, 7(1): 402. https://doi.org/10.1038/s41392-022-01257-8 Xi S., Chen W., and Ke Y., 2024, Advances in SIRT3 involvement in regulating autophagy-related mechanisms, Cell Division, 19(1): 20. https://doi.org/10.1186/s13008-024-00124-y Xian Y., Liu B., Shen T., Yang L., Peng R., Shen H., An X., Wang Y.T., Ben Y, Jiang Q., and Guo B., 2025, Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus, Bone Research, 13(1): 30. https://doi.org/10.1038/s41413-024-00399-5 Xin T., and Lu C., 2020, SirT3 activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury, Aging, 12(16): 16224. https://doi.org/10.18632/aging.103644 Xu Y., Zhang S., Rong J., Lin Y., Du L., Wang Y., and Zhang Z., 2020, Sirt3 is a novel target to treat sepsis induced myocardial dysfunction by acetylated modulation of critical enzymes within cardiac tricarboxylic acid cycle, Pharmacological Research, 159: 104887. https://doi.org/10.1016/j.phrs.2020.104887 Yu W., Gao B., Li N.A., Wang J., Qiu C., Zhang G., Liu M., Zhang R., Li C., Ji G., and Zhang Y., 2017, Sirt3 deficiency exacerbates diabetic cardiac dysfunction: role of Foxo3A-Parkin-mediated mitophagy, Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1863(8): 1973-1983. https://doi.org/10.1016/j.bbadis.2016.10.021 Zakynthinos G.E., Giamouzis G., Xanthopoulos A., Oikonomou E., Kalogeras K., Karavidas N., Dimeas I.E., Gialamas I., Gounaridi M.I., Siasos G., Vavuranakis M., Zakynthinos E., and Tsolaki V., 2025, Septic cardiomyopathy: difficult definition challenging diagnosis unclear treatment, Journal of Clinical Medicine, 14(3): 986. https://doi.org/10.3390/jcm14030986 Zhang J., Xiang H., Liu J., Chen Y., He R.R., and Liu B., 2020a, Mitochondrial sirtuin 3: new emerging biological function and therapeutic target, Theranostics, 10(18): 8315. https://doi.org/10.7150/thno.45922 Zhang Q., Siyuan Z., Xing C., and Ruxiu L., 2024, SIRT3 regulates mitochondrial function: a promising star target for cardiovascular disease therapy, Biomedicine and Pharmacotherapy, 170: 116004. https://doi.org/10.1016/j.biopha.2023.116004 Zhang W., Zhang S., Yan P., Ren J., Song M., Li J., Lei J, Pan H., Wang S., Ma X., Ma S., Li H.Y., Sun F., Wan H.F., Li W., Chan P., Zhou Q., Liu G.H., Tang F.C., and Qu J., 2020b, A single-cell transcriptomic landscape of primate arterial aging, Nature Communications, 11(1): 2202. https://doi.org/10.1038/s41467-020-15997-0 Zhao Y., and Liu Y.S., 2021, Longevity factor FOXO3: a key regulator in aging-related vascular diseases, Frontiers in Cardiovascular Medicine, 8: 778674. https://doi.org/10.3389/fcvm.2021.778674
RkJQdWJsaXNoZXIy MjQ4ODYzNA==